Evommune, Inc.

U.S. stock futures traded below the flatline on Wednesday as oil prices climbed above $100 a barrel and investors awaited inflation data that could reinforce expectations for the Federal Reserve to raise interest rates later this month. By 06:13 ET, S&P 500 futures had fallen 19 points, or 0.3%, while Nasdaq 100 futures were down 134 points, or 0.5%, and Dow Jones futures had slipped 206 points, or 0.4%. Meta Platforms shares surged 3.6% in premarket trading after the company launched Muse, its autonomous AI personal agent, and introduced a tiered AI subscription model with plans at $20 and $100 per month. Evommune shares fell 13.9% to $11.26 after its EVO756 drug candidate failed to meet primary and secondary endpoints in a Phase 2b trial for atopic dermatitis, and the company will not advance it in that indication. Braze shares tumbled 11.5% despite beating fiscal second-quarter estimates, as its third-quarter profit guidance fell short of consensus and growth showed signs of slowing. NETGEAR shares jumped 8.9% after the FCC banned imports of new consumer routers manufactured outside the U.S., a move that could benefit NETGEAR due to its existing FCC approval exemption.